Anthem Biosciences Ltd.
Issue Open Date 14-Jul-25  
Issue Closing Date 16-Jul-25  
Application Money 100  
Allotment Money  
Price Band () 540 - 570  
Minimum Bid Quantity. 26  
Issue Size (Shares) 44070682  
Market Lot 1  
Objective

(i) to carry out the Offer for Sale of up to [?] Equity Shares of face value of ? 2 each by theSelling Shareholders aggregating up to ? 33,950.00 million and(ii) achieve the benefits of listing the Equity Shares on the Stock Exchanges.

Business Description

We are an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization(“CRDMO”) with fully integrated operations spanning across drug discovery, development and manufacturing. We are one ofthe few companies in India with integrated New Chemical Entity (“NCE”) and New Biological Entity (“NBE”) capabilitiesacross drug discovery, development, and commercia...

Promoter's Holding
Total Share Capital   431747949  
Offered to Public   44070682  
Promoter's Holding (Pre-Issue)   77.23  
Promoter's Holding (Post-Issue)    
Address
Address :No. 49
F1 & F2
Canara Bank Road
Bommasandra Industrial Area
Phase I
Bommasandra
City :Bengaluru, State :Karnataka Pincode :560099 Phone :080-66724000 Email : investors.abl@anthembio.com Website : www.anthembio.com
Registrar
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B
Plot 31-32
Gachibowli
Financial District
Nanakramguda
Hyderabad
Listed at
BSE, NSE
Lead Manager
Citigroup Global Markets India Pvt Ltd.
JM Financial Ltd.
JP Morgan India Pvt Ltd
Nomura Financial Advisory & Securities (India) Pvt Ltd.
Promoters
Ajay Bhardwaj
Ganesh Sambasivam
Ishaan Bhardwaj
K Ravindra Chandrappa

© 2019. MSE Financial Services Ltd. All Rights Reserved

Developed & Content Powered by  Accord Fintech Pvt. Ltd.